Drug search by name

Phendimetrazine Extended-Release Capsules and Pulmonary hypertension

Result of checking the interaction of drug Phendimetrazine Extended-Release Capsules and disease Pulmonary hypertension for safety when used together.

Check result:

Phendimetrazine Extended-Release Capsules <> Pulmonary hypertension

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of some CNS stimulants has been associated with an increased risk of developing pulmonary hypertension, a rare but fatal disorder. The onset or aggravation of exertional dyspnea, or unexplained symptoms of angina pectoris, syncope, or lower extremity edema suggest the possibility of occurrence of pulmonary hypertension. Under these circumstances, treatment must be immediately discontinued, and the patient should be evaluated to confirm diagnosis. Caution should be exercised in patients with preexisting valvular heart disease or history of pulmonary hypertension. These drugs are not recommended in patients with known heart murmur or valvular heart disease.

Phendimetrazine Extended-Release Capsules

Generic Name: phendimetrazine

Brand Name: Bontril, Melfiat, Bontril PDM

Synonyms: Phendimetrazine

What is Phendimetrazine Extended-Release Capsules?